Olympiad Research LP Takes Position in Option Care Health, Inc. (NASDAQ:OPCH)

Olympiad Research LP bought a new stake in Option Care Health, Inc. (NASDAQ:OPCH) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 15,520 shares of the company’s stock, valued at approximately $360,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. New York State Common Retirement Fund raised its holdings in Option Care Health by 14.6% in the fourth quarter. New York State Common Retirement Fund now owns 246,034 shares of the company’s stock valued at $5,708,000 after acquiring an additional 31,400 shares in the last quarter. Kornitzer Capital Management Inc. KS raised its holdings in Option Care Health by 2.5% in the fourth quarter. Kornitzer Capital Management Inc. KS now owns 444,095 shares of the company’s stock valued at $10,303,000 after acquiring an additional 10,900 shares in the last quarter. Venturi Wealth Management LLC raised its holdings in Option Care Health by 2,621.3% in the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock valued at $110,000 after acquiring an additional 4,561 shares in the last quarter. Principal Financial Group Inc. raised its holdings in Option Care Health by 0.9% in the fourth quarter. Principal Financial Group Inc. now owns 479,255 shares of the company’s stock valued at $11,119,000 after acquiring an additional 4,166 shares in the last quarter. Finally, State of New Jersey Common Pension Fund D raised its holdings in Option Care Health by 52.1% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 96,204 shares of the company’s stock valued at $2,232,000 after acquiring an additional 32,972 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Stock Down 1.2 %

OPCH stock opened at $32.00 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.63. The firm’s 50-day simple moving average is $27.71 and its 200 day simple moving average is $27.98. The stock has a market cap of $5.45 billion, a PE ratio of 26.89, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35.

Analyst Ratings Changes

Several analysts recently issued reports on OPCH shares. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price target (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. JPMorgan Chase & Co. upped their price target on shares of Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Barrington Research increased their target price on shares of Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a report on Tuesday, January 14th. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and increased their target price for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Finally, Truist Financial dropped their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $32.25.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.